Data / Research funding / Maryland / Henry M. Jackson FDN for the Adv Mil/med
Henry M. Jackson FDN for the Adv Mil/med: 80 NIH awards ($108.6M) and 1 NSF award ($651.8K), fiscal years 2021 to 2026
Henry M. Jackson FDN for the Adv Mil/med in Bethesda, MD is funded under 80 NIH awards ($108.6M) and 1 NSF award ($651.8K) in the NIH and NSF award files, read 2026-11-03. NIH fiscal years 2021 to 2025; NSF fiscal years 2022 to 2026.
SpecStream is the live web data engine for teams and agents. It reads the NIH and NSF award files each time the agencies update them, and this page is that reading, joined to the open federal funding opportunities on Grants.gov. Ask for the awards you track by topic, organization or state and new awards arrive in your sheet, CRM, Slack or agent as the agencies publish them.
- UEI
- UYLKBRENAPG5
- State
- Maryland
Awards
81 awards in the window.
| Award | Agency | Institute or division | Fiscal year | Amount in window | Start | End | Principal investigator | Source |
|---|---|---|---|---|---|---|---|---|
| Advancement of Vaccines and Therapies for Henipaviruses | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2023 | $16,013,774 | March 20, 2019 | February 28, 2026 | BRODER, CHRISTOPHER C | reporter.nih.gov |
| The Military HIV Research Program (MHRP) Clinical Trial Unit | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $9,910,676 | December 10, 2013 | November 30, 2027 | ROBB, MERLIN L | reporter.nih.gov |
| The Gonorrhea Vaccine Cooperative Research Center | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2023 | $6,384,930 | March 26, 2019 | February 28, 2025 | JERSE, ANN E. | reporter.nih.gov |
| Center for Immunological Interventions against Gonorrhea (CIIG) | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $4,362,124 | August 12, 2025 | June 30, 2030 | JERSE, ANN E. | reporter.nih.gov |
| Targeting HIV reservoirs in children with HIVIS DNA and MVA-CMDR vaccines | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $4,251,563 | February 1, 2018 | February 28, 2026 | ROBB, MERLIN L | reporter.nih.gov |
| Understanding Pandemic Evolution through Networked Data (UPEND) | NIH | National Institute of Mental Health | 2023 | $3,822,251 | April 15, 2023 | April 14, 2026 | CROWELL, TREVOR ADAM | reporter.nih.gov |
| Evaluation of Antibody Responses Elicited by Zika Vaccination in Flavivirus-naïve and -experienced Individuals | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $3,665,742 | April 13, 2021 | March 31, 2027 | KREBS, SHELLY J | reporter.nih.gov |
| Designing HIV-1 envelope immunogens to maximize neutralization breadth through use of multiple founder envelope antigens | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $3,259,509 | June 20, 2023 | May 31, 2027 | BOLTON, DIANE L. | reporter.nih.gov |
| Antiglutamatergic Therapy to Protect the Brain Against Nerve Agents | NIH | National Institute of Neurological Disorders and Stroke | 2022 to 2025 | $2,969,523 | September 1, 2022 | August 31, 2027 | BRAGA, MARIA F. | reporter.nih.gov |
| Impact of IL-15 immunotherapy on tissue-specific CD8 T cells to reduce the CNS HIV reservoir seeding and persistence | NIH | National Institute of Mental Health | 2023 to 2025 | $2,924,235 | June 1, 2023 | May 31, 2027 | TRAUTMANN, LYDIE | reporter.nih.gov |
| Maturation of human humoral immunity through repeat malaria challenges | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $2,367,571 | May 24, 2023 | April 30, 2028 | WILLIAMSON, KIM C | reporter.nih.gov |
| Leveraging genetic and electronic health record data to identify novel targets and drugs for treating alcohol use disorder | NIH | National Institute on Alcohol Abuse and Alcoholism | 2022 to 2025 | $2,289,275 | June 1, 2022 | May 31, 2027 | GRAY, JOSHUA CHARLES | reporter.nih.gov |
| A new strategy to eliminate HIV-1-infected cells by unlocking the Env trimer | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $2,106,653 | August 7, 2023 | July 31, 2027 | PAZGIER, MARZENA ELZBIETA | reporter.nih.gov |
| Mechanistic elucidation of pathogenic CBM complex mutations associated with atopic disease | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $2,100,471 | July 5, 2023 | June 30, 2028 | SNOW, ANDREW L | reporter.nih.gov |
| Plasmodium falciparum gametocytogenesis in vitro and in vivo | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $2,054,301 | January 8, 2020 | December 31, 2025 | WILLIAMSON, KIM C | reporter.nih.gov |
| Calcium Dysregulation and Cell Function in Spinal Muscular Atrophy | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $1,951,881 | January 20, 2021 | December 31, 2026 | FLAGG, THOMAS | reporter.nih.gov |
| Mitigation of Radiation Induced Immune Dysfunction by PrC-210 Treatment | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $1,943,889 | August 17, 2022 | May 31, 2027 | KUMAR, VIDYA P. | reporter.nih.gov |
| Temporal and Metabolic Regulation of Restimulation-Induced Cell Death (RICD) in Human T Cells | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $1,927,925 | January 1, 2021 | December 31, 2026 | SNOW, ANDREW L | reporter.nih.gov |
| Regulation of cytoplasmic dynein in vivo | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $1,906,200 | September 1, 2021 | August 31, 2027 | XIANG, XIN | reporter.nih.gov |
| COVID-19 airway inflammation is due to Spike inhibition of CFTR signaling | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $1,873,689 | January 15, 2023 | December 31, 2026 | POLLARD, HARVEY BRUCE | reporter.nih.gov |
| Pluripotent stem cell-derived organoid model of human gonad development, functions, and disorders | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2023 to 2025 | $1,746,338 | September 18, 2023 | August 31, 2027 | JORDAN, PHILIP W | reporter.nih.gov |
| Isoform-specific signaling as a determinant of RAS-driven oncogenesis | NIH | National Cancer Institute | 2022 to 2025 | $1,370,920 | February 1, 2022 | January 31, 2027 | KORTUM, ROBERT | reporter.nih.gov |
| Evolution of Homologous Recombination Mechanisms | NIH | National Institute of General Medical Sciences | 2021 to 2024 | $1,351,551 | April 1, 2015 | March 31, 2026 | PETUKHOVA, GALINA | reporter.nih.gov |
| Cellular organization, division, and differentiation in an ancient, genetically reduced bacterium | NIH | National Institute of General Medical Sciences | 2021 to 2024 | $1,337,023 | August 1, 2020 | May 31, 2026 | LIECHTI, GEORGE WARREN | reporter.nih.gov |
| Regulation of microtubule organizing centers during mammalian gametogenesis | NIH | National Institute of General Medical Sciences | 2022 to 2025 | $1,207,922 | January 1, 2016 | March 31, 2029 | JORDAN, PHILIP W | reporter.nih.gov |
| Role of the enterococcal site 2 protease in biofilm formation, adaptation, and host-pathogen interactions | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2023 | $1,109,967 | December 13, 2018 | December 31, 2025 | FRANK, KRISTI L | reporter.nih.gov |
| The Mechanistic Basis of Selective ER-Export of Misfolded Secretory Pathway Proteins | NIH | National Institute of General Medical Sciences | 2021 to 2023 | $932,373 | September 3, 2019 | July 31, 2025 | SATPUTE-KRISHNAN, PRASANNA | reporter.nih.gov |
| Extracellular matrix sensing in cellular signaling, migration and wound repair | NIH | National Institute of General Medical Sciences | 2021 to 2023 | $932,373 | September 1, 2019 | August 31, 2025 | ROTTY, JEREMY | reporter.nih.gov |
| Respiratory mucosal immune development in early life and the quest for protective local memory against respiratory syncytial virus. | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2023 | $897,958 | May 8, 2020 | April 30, 2025 | MALLOY, ALLISON MARIE WAHL | reporter.nih.gov |
| Role of Ly6K in TGF-beta and immune escape pathways of triple negative breast cancer | NIH | National Cancer Institute | 2021 to 2022 | $787,739 | August 3, 2018 | July 31, 2025 | UPADHYAY, GEETA | reporter.nih.gov |
| Induction of tolerance to FVIII by engineered T regulatory cells in hemophilia | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $739,978 | May 6, 2015 | June 30, 2024 | SCOTT, DAVID WILLIAM | reporter.nih.gov |
| The Mechanisms and Functional Consequences of Interhemispheric Plasticity | NIH | National Institute of Neurological Disorders and Stroke | 2022 to 2024 | $739,530 | September 1, 2019 | May 31, 2026 | PETRUS, EMILY ROSE | reporter.nih.gov |
| Molecular analysis of MEHMO syndrome mutations in translation factor eIF2 | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2022 to 2024 | $738,591 | December 1, 2021 | November 30, 2025 | YOUNG-BAIRD, SARA KATHRYN | reporter.nih.gov |
| Collaborative Research: Integrating Phylogenomics and Traits to Reveal the Eco-Evolutionary Range Dynamics of Anopheline Mosquitos | NSF | Evolutionary Patterns & Processes | 2026 | $651,779 | August 1, 2026 | July 31, 2029 | Mohamed Sallam | nsf.gov |
| Clu forms a dynamic new ribonucleoprotein particle directly involved in mitochondrial function | NIH | National Institute of General Medical Sciences | 2021 to 2022 | $649,695 | August 1, 2019 | November 30, 2024 | COX, RACHEL TAFEL | reporter.nih.gov |
| T cell receptor-activated autophagy as a regulator of T cell effector responses | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $612,989 | June 16, 2017 | May 31, 2024 | SCHAEFER, BRIAN | reporter.nih.gov |
| Development of angiogenin as a novel radiation medical countermeasure for acute radiation syndrome | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $554,698 | September 4, 2025 | July 31, 2030 | SINGH, VIJAY K | reporter.nih.gov |
| Structure-based identification of pan-arenavirus sites of vulnerability | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $536,871 | August 1, 2025 | July 31, 2027 | JOYCE, MICHAEL GORDON | reporter.nih.gov |
| Determining the interplay of MAIT cells and the translocated microbiome in HIV-induced neuroinflammation | NIH | National Institute of Mental Health | 2023 | $492,992 | September 1, 2023 | August 31, 2025 | PAQUIN-PROULX, DOMINIC | reporter.nih.gov |
| NK cell memory subsets and their impact on HIV disease progression and vaccination | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2023 | $482,680 | August 1, 2022 | July 31, 2025 | MACHMACH LEGGAT, KAWTHAR | reporter.nih.gov |
| Inflammation and white matter microstructural alterations after OP exposure | NIH | National Institute of Neurological Disorders and Stroke | 2024 to 2025 | $478,554 | August 1, 2024 | July 31, 2027 | MARINI, ANN M | reporter.nih.gov |
| Impact of Microbial Dysbiosis on MAIT Cell Tissue Repair Program after Acute HIV Infection | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2023 | $470,026 | July 15, 2022 | April 30, 2025 | PAQUIN-PROULX, DOMINIC | reporter.nih.gov |
| ATR Dependency as a Novel Therapeutic Target in Lethal RB Deficient ProstateCancer | NIH | National Cancer Institute | 2023 to 2025 | $454,198 | June 8, 2020 | February 28, 2027 | ELLIS, LEIGH | reporter.nih.gov |
| Assessing the role of liver stage antigens-specific antibodies against Plasmodium falciparum liver stage infection | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $445,142 | April 15, 2021 | October 31, 2024 | KRZYCH, URSZULA | reporter.nih.gov |
| Unlocking Envelope: A New Strategy for a Functional Cure Through Antibody-Dependent Cell-Mediated Cytotoxicity | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $444,371 | May 3, 2019 | September 30, 2023 | PAZGIER, MARZENA ELZBIETA | reporter.nih.gov |
| RNA and DNA sensors in the response of macrophages to ionizing radiation | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $438,832 | May 15, 2024 | March 31, 2027 | IORDANSKIY, SERGEY | reporter.nih.gov |
| Identifying the radioprotective potential of radiation-resistant fungi using Drosophila | NIH | Office of the Director, National Institutes of Health | 2024 to 2025 | $438,832 | August 1, 2024 | July 31, 2027 | COX, RACHEL TAFEL | reporter.nih.gov |
| Does joint lavage reduce intraarticular inflammation in high-energy tibial pilon fractures? | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2022 to 2024 | $427,288 | August 5, 2022 | July 31, 2025 | WHEATLEY, BENJAMIN M | reporter.nih.gov |
| FL2 siRNA as a Novel Therapeutic Option to Induce Spinal Cord Regeneration Following Injury | NIH | National Institute of Neurological Disorders and Stroke | 2022 | $425,702 | September 24, 2022 | August 31, 2025 | BYRNES, KIMBERLY | reporter.nih.gov |
| Lateral habenula circuit dysregulation in mild traumatic brain injury | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2023 | $419,365 | January 1, 2021 | December 31, 2024 | NUGENT, FERESHTEH S | reporter.nih.gov |
| A new Drosophila model of astrocyte calcium signaling in chronic pain | NIH | National Institute of Neurological Disorders and Stroke | 2021 | $419,365 | June 1, 2021 | November 30, 2023 | SMYTH, JEREMY THOMAS | reporter.nih.gov |
| Contribution of Helicobacter pylori HomA and HomB to colonization and disease | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $419,365 | June 21, 2021 | May 31, 2025 | MELTON-CELSA, ANGELA | reporter.nih.gov |
| Interaction of Galectin-9 and Pregnancy-Specific Glycoprotein 1 in the Regulation of Cells of the Innate and Adaptive Immune System | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $419,365 | June 18, 2021 | May 31, 2025 | DVEKSLER, GABRIELA S | reporter.nih.gov |
| Not all members of the pregnancy-specific glycoprotein family are created equal | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2023 | $417,815 | May 1, 2022 | April 30, 2026 | DVEKSLER, GABRIELA S | reporter.nih.gov |
| Host Ca2+, actin, and ATP production in rickettsia-endothelial cell dysfunction | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2023 | $417,621 | July 5, 2022 | June 30, 2024 | DUMLER, JOHN STEPHEN | reporter.nih.gov |
| HTLV-1 Replication/Reactivation-Induced DNA Damage: Mechanisms and Pathogenesis | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2024 | $417,621 | November 14, 2022 | October 31, 2025 | SNOW, ANDREW L | reporter.nih.gov |
| Intrinsic CRF signaling within the lateral habenula | NIH | National Institute of Mental Health | 2023 to 2024 | $417,621 | March 2, 2023 | February 28, 2026 | NUGENT, FERESHTEH S | reporter.nih.gov |
| Advanced Image Analysis Tools for Super-Resolved MRI in Small Animals | NIH | Office of the Director, National Institutes of Health | 2021 to 2022 | $401,527 | August 15, 2021 | July 31, 2024 | PHAM, DZUNG L | reporter.nih.gov |
| Thalamostriatal circuit contributions to behavioral inflexibility following adolescent ethanol exposure | NIH | National Institute on Alcohol Abuse and Alcoholism | 2022 to 2023 | $400,302 | March 1, 2022 | July 31, 2023 | JOHNSON, KARI | reporter.nih.gov |
| Use of Ly6K specific CAR T-cells to treat primary and metastatic triple negative breast cancer | NIH | National Cancer Institute | 2021 to 2022 | $388,542 | September 1, 2021 | August 31, 2025 | UPADHYAY, GEETA | reporter.nih.gov |
| Preventing Therapeutic Resistance in RAS-mutated Pediatric Cancers | NIH | National Cancer Institute | 2022 to 2024 | $388,540 | February 1, 2022 | January 31, 2026 | KORTUM, ROBERT | reporter.nih.gov |
| Regulation of protein synthesis during cellular stress | NIH | National Institute of General Medical Sciences | 2025 | $372,880 | May 1, 2025 | April 30, 2030 | YOUNG-BAIRD, SARA KATHRYN | reporter.nih.gov |
| Astrocyte Calcium Signaling in Chronic Pain. | NIH | National Institute of Neurological Disorders and Stroke | 2025 | $372,880 | August 1, 2025 | May 31, 2030 | SMYTH, JEREMY THOMAS | reporter.nih.gov |
| QALYs, Comorbidities, and Cost-effectiveness of HIV Care in the Department of Defense vs the Veterans Health Administration | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $361,183 | August 1, 2024 | June 30, 2027 | AGAN, BRIAN | reporter.nih.gov |
| Mechanisms of Radiation-induced Hemolysis | NIH | National Institute of Environmental Health Sciences | 2025 | $340,383 | September 22, 2025 | September 21, 2027 | DAY, REGINA M | reporter.nih.gov |
| Retrospective Magnetic Resonance Image Harmonization for Robust Federated Learning | NIH | National Library of Medicine | 2025 | $320,622 | July 28, 2025 | May 31, 2029 | PHAM, DZUNG L | reporter.nih.gov |
| Improving Interpretation of Hearing- Related Patient Reported Outcomes for Bilingual Adults | NIH | National Institute on Deafness and Other Communication Disorders | 2024 to 2025 | $301,234 | August 1, 2024 | July 31, 2027 | BIEBER, REBECCA | reporter.nih.gov |
| Role of primaquine pharmacokinetics in treatment efficacy for vivax malaria | NIH | National Institute of Allergy and Infectious Diseases | 2022 | $284,968 | June 10, 2022 | May 31, 2023 | SPRING, MICHELE | reporter.nih.gov |
| The Mouse Model System for Targeted Trimming of Disease Susceptibility Loci | NIH | Office of the Director, National Institutes of Health | 2025 | $261,017 | May 1, 2025 | April 30, 2027 | PETUKHOVA, GALINA | reporter.nih.gov |
| Presynaptic modulation of corticostriatal transmission following chronic ethanol exposure | NIH | National Institute on Alcohol Abuse and Alcoholism | 2021 | $248,624 | September 20, 2017 | July 31, 2023 | JOHNSON, KARI | reporter.nih.gov |
| Quantifying Locomotor Outcomes with Agonist-Antagonist Myoneural Interface | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2024 | $240,722 | August 1, 2024 | July 31, 2026 | BUTOWICZ, COURTNEY M. | reporter.nih.gov |
| Delineating the kinetics of spinal pathology in the EV-D68 infected ferret model | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $217,976 | February 1, 2025 | January 31, 2027 | MATTAPALLIL, JOSEPH JOHN | reporter.nih.gov |
| Assessing if distinct susceptibility to neutralization of cell-free and cell-to-cell spread impacts antibody conferred protection from SHIV infection | NIH | Office of the Director, National Institutes of Health | 2023 | $213,057 | May 15, 2021 | August 31, 2025 | PARSONS, MATTHEW SIDNEY | reporter.nih.gov |
| Engineering Specific Regulatory T Cells to Treat Allergy | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $190,621 | April 6, 2020 | September 30, 2023 | SCOTT, DAVID WILLIAM | reporter.nih.gov |
| Mapping the genes that predispose to murine lupus | NIH | National Institute of Allergy and Infectious Diseases | 2022 | $190,621 | February 1, 2020 | January 31, 2024 | VIA, CHARLES S. | reporter.nih.gov |
| Development of the ferret model for EV-D68 infection | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $152,496 | September 15, 2020 | August 31, 2024 | MATTAPALLIL, JOSEPH JOHN | reporter.nih.gov |
| Evaluation of PEG-BPEI as a potential mitigator against gastrointestinal acute radiation syndrome | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $149,008 | August 1, 2025 | July 31, 2027 | KUMAR, VIDYA P. | reporter.nih.gov |
| Impact of the COVID-19 Pandemic on Alcohol Use and Outcomes: The Role of Health Disparities | NIH | National Institute on Alcohol Abuse and Alcoholism | 2022 to 2023 | $61,346 | July 1, 2022 | June 30, 2024 | VAUGHAN, COURTNEY LYNN | reporter.nih.gov |
| Determine the Role of Microglia in Adult Circuit Remodeling in a Mouse Model of Whisker Denervation | NIH | National Institute of Neurological Disorders and Stroke | 2025 | $33,538 | January 5, 2026 | July 4, 2028 | COLLIER, SEAN | reporter.nih.gov |
| Identifying EZH2-dependent vulnerabilities in RB deficient prostate cancer | NIH | National Cancer Institute | 2022 | $33,446 | May 25, 2021 | November 30, 2024 | ELLIS, LEIGH | reporter.nih.gov |
| Examining Suicide Risk from a Biopsychosocial Framework: A Large-Scale Cross-Sectional Study | NIH | National Institute of Mental Health | 2022 | $25,170 | August 15, 2022 | June 9, 2023 | THOMPSON, MATTHEW | reporter.nih.gov |
Funding by fiscal year
| Fiscal year | NIH awards | NIH amount | NSF awards | NSF amount |
|---|---|---|---|---|
| 2026 | 0 | $0 | 1 | $651,779 |
| 2025 | 34 | $20,829,767 | 0 | $0 |
| 2024 | 33 | $15,918,476 | 0 | $0 |
| 2023 | 44 | $30,537,862 | 0 | $0 |
| 2022 | 42 | $22,156,725 | 0 | $0 |
| 2021 | 30 | $19,187,326 | 0 | $0 |
Open federal funding opportunities
From Grants.gov: notices that funded awards in this table, and open notices on the same agency and assistance listing.
| Open opportunity | Number | Agency | Listing | Closes | Award ceiling | Why it matches |
|---|---|---|---|---|---|---|
| Infectious Diseases Clinical Trials Network (IDCTN) (UM1 Clinical Trial Required) | RFA-AI-27-002 | NIH | 93.855 | November 10, 2026 | Not listed | Same assistance listing 93.855 as 33 awards here |
| Clinical Research Network on Antimicrobial Resistance (UM1 Clinical Trial Required) | RFA-AI-27-005 | NIH | 93.855 | November 10, 2026 | Not listed | Same assistance listing 93.855 as 33 awards here |
| Ethical, Legal and Social Implications (ELSI) Small Research Grant (R03 Clinical Trial Optional) | PAR-25-370 | NIH | 93.855 | November 16, 2026 | $50,000 | Same assistance listing 93.855 as 33 awards here |
| Ethical, Legal and Social Implications (ELSI) Exploratory/Developmental Research Grant (R21 Clinical Trial Optional) | PAR-25-369 | NIH | 93.855 | November 18, 2026 | Not listed | Same assistance listing 93.855 as 33 awards here |
| Ethical, Legal and Social Implications (ELSI) Research (R01 Clinical Trial Optional) | PAR-25-371 | NIH | 93.855 | November 18, 2026 | Not listed | Same assistance listing 93.855 as 33 awards here |
| Intervention Research to Improve Native American Health (R01 Clinical Trial Optional) | PAR-25-379 | NIH | 93.855 | January 7, 2027 | Not listed | Same assistance listing 93.855 as 33 awards here |
| HIV/AIDS Clinical Trials Network Leadership and Operations Centers | RFA-AI-28-001 | NIH | 93.855 | January 22, 2027 | Not listed | Same assistance listing 93.855 as 33 awards here |
| HIV/AIDS Clinical Trials Network Laboratory Centers | RFA-AI-28-002 | NIH | 93.855 | January 22, 2027 | Not listed | Same assistance listing 93.855 as 33 awards here |
| HIV/AIDS Clinical Trials Network Statistical and Data Management Centers | RFA-AI-28-003 | NIH | 93.855 | January 22, 2027 | Not listed | Same assistance listing 93.855 as 33 awards here |
| HIV/AIDS Clinical Trials Network Clinical Trials Units | RFA-AI-28-004 | NIH | 93.855 | January 22, 2027 | Not listed | Same assistance listing 93.855 as 33 awards here |
| Precision and Systems Biology to Uncover the Link Between Chronic and Infectious Diseases | RFA-AI-28-014 | NIH | 93.855 | January 22, 2027 | Not listed | Same assistance listing 93.855 as 33 awards here |
| Immune Tolerance Network (UM1 Clinical Trial Required) | RFA-AI-28-005 | NIH | 93.855 | January 29, 2027 | Not listed | Same assistance listing 93.855 as 33 awards here |
| Translational Centers Using Microphysiological Systems for Infectious Diseases (U54 Clinical Trial Not Allowed) | RFA-AI-28-012 | NIH | 93.855 | January 29, 2027 | Not listed | Same assistance listing 93.855 as 33 awards here |
| Accelerating Research and Development of Next Generation Vaccines against Malaria - a Model for Mosquito-Borne Diseases (R61/R33 Clinical Trial Not Allowed) | RFA-AI-28-024 | NIH | 93.855 | February 11, 2027 | Not listed | Same assistance listing 93.855 as 33 awards here |
| NLM Institutional Grants for Research Training in Biomedical Informatics, Data Science, and AI (T15 Independent Clinical Trial Not Allowed) | RFA-LM-28-001 | NIH | 93.855 | February 11, 2027 | $775,000 | Same assistance listing 93.855 as 33 awards here |
| NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional) | PA-27-100 | NIH | 93.855 | April 5, 2027 | Not listed | Same assistance listing 93.855 as 33 awards here |
| NIH Small Business Technology Transfer Grant (Parent STTR [R41/R42] Clinical Trial Optional) | PA-27-102 | NIH | 93.855 | April 5, 2027 | Not listed | Same assistance listing 93.855 as 33 awards here |
| Mentored Research Scientist Development Award (Parent K01 - Independent Clinical Trial Not Allowed) | PA-24-176 | NIH | 93.855 | May 7, 2027 | Not listed | Same assistance listing 93.855 as 33 awards here |
| Mentored Patient-Oriented Research Career Development Award (Parent K23 Independent Clinical Trial Not Allowed) | PA-24-185 | NIH | 93.855 | May 7, 2027 | Not listed | Same assistance listing 93.855 as 33 awards here |
| Midcareer Investigator Award in Patient-Oriented Research (Parent K24 Independent Clinical Trial Required) | PA-24-187 | NIH | 93.855 | May 7, 2027 | Not listed | Same assistance listing 93.855 as 33 awards here |
Topics of its NIH awards
- Infectious Diseases
- Biotechnology
- Neurosciences
- Rare Diseases
- Genetics
- Biodefense and Related Countermeasures
- Clinical Research
- Immunization
- Prevention
- Emerging Infectious Diseases
- Pediatric
- HIV/AIDS
Updated November 3, 2026. Read from NIH RePORTER ExPORTER and NSF Award Search. Published by NIH and NSF as U.S. government data. NIH awards are fiscal years 2021 to 2025 (NIH files published to 2026-07-09); NSF awards are fiscal years 2022 to 2026 (NSF files published to 2026-11-02). NIH amounts are the total cost of each fiscal year in the window; NSF amounts are the funds obligated in the window. Organizations are matched on the UEI. Open opportunities come from Grants.gov and match on agency and assistance listing number, and on the notice number NIH prints on an award. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.